Techno Medica Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Net Income	1,319	1,860	1,665	1,851	1,649	Upgrade
Depreciation & Amortization	99	112	108	120	120	Upgrade
Loss (Gain) From Sale of Assets	-	9	2	-	-	Upgrade
Other Operating Activities	-572	-493	-642	-628	-261	Upgrade
Change in Accounts Receivable	392	-723	77	-46	-283	Upgrade
Change in Inventory	-452	-289	-636	416	-286	Upgrade
Change in Accounts Payable	160	-84	217	147	53	Upgrade
Change in Other Net Operating Assets	31	750	96	202	-167	Upgrade
Operating Cash Flow	977	1,142	887	2,062	825	Upgrade
Operating Cash Flow Growth	-14.45%	28.75%	-56.98%	149.94%	-34.99%	Upgrade
Capital Expenditures	-25	-37	-133	-66	-30	Upgrade
Sale (Purchase) of Intangibles	-6	-64	-5	-14	-3	Upgrade
Investment in Securities	-	-	-	2,568	-120	Upgrade
Other Investing Activities	-1	1	-17	1	-	Upgrade
Investing Cash Flow	-32	-100	-155	2,489	-153	Upgrade
Repurchase of Common Stock	-	-3,697	-	-164	-	Upgrade
Dividends Paid	-470	-508	-505	-434	-415	Upgrade
Financing Cash Flow	-470	-4,205	-505	-598	-415	Upgrade
Miscellaneous Cash Flow Adjustments	-	-	-1	-	-1	Upgrade
Net Cash Flow	475	-3,163	226	3,953	256	Upgrade
Free Cash Flow	952	1,105	754	1,996	795	Upgrade
Free Cash Flow Growth	-13.85%	46.55%	-62.22%	151.07%	-6.03%	Upgrade
Free Cash Flow Margin	9.61%	10.75%	8.05%	20.58%	8.79%	Upgrade
Free Cash Flow Per Share	137.48	141.76	89.34	234.98	93.60	Upgrade
Cash Income Tax Paid	574	495	644	630	260	Upgrade
Levered Free Cash Flow	674.5	772	572.63	1,817	667	Upgrade
Unlevered Free Cash Flow	674.5	772	572.63	1,817	667	Upgrade
Change in Net Working Capital	206	389	428	-629	425	Upgrade

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.